Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--non-human viral transmission.
作者信息
Robertson J S
机构信息
National Institute for Biological Standards and Control, Potters Bar, Hertfortshire, United Kingdom.
出版信息
Ann Hematol. 1994;68 Suppl 3:S81-2. doi: 10.1007/BF01774543.
PMID:8180263
Abstract
摘要
相似文献
1
Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--non-human viral transmission.对既往未治疗和已治疗患者、未感染病毒和感染病毒患者的长期监测研究——非人类病毒传播。
Ann Hematol. 1994;68 Suppl 3:S81-2. doi: 10.1007/BF01774543.
2
Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--antibodies and reactions.对既往未治疗和已治疗患者、病毒未感染和已感染患者的长期监测研究——抗体与反应。
Ann Hematol. 1994;68 Suppl 3:S79-80. doi: 10.1007/BF01774542.
3
Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--impact on the immune and other systems.对既往未治疗和已治疗患者、病毒未感染和已感染患者的长期监测研究——对免疫及其他系统的影响。
Ann Hematol. 1994;68 Suppl 3:S83-6. doi: 10.1007/BF01774544.
4
Viral safety issues: plasma-derived factor VIII.病毒安全性问题：血浆源性凝血因子VIII。
Ann Hematol. 1994;68 Suppl 3:S35-6. doi: 10.1007/BF01774528.
5
Concentrate safety and efficacy.
Haemophilia. 2002 May;8(3):161-5. doi: 10.1046/j.1365-2516.2002.00601.x.
6
Viral safety of plasma-derived factor VIII and IX concentrates.
Blood Coagul Fibrinolysis. 1997 Aug;8 Suppl 1:S19-23.
7
[Virus in hemophilia: current status and future perspectives].[血友病中的病毒：现状与未来展望]
Sangre (Barc). 1996 Apr;41(2):141-5.
8
Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate.
Haemophilia. 2008 May;14(3):612-4. doi: 10.1111/j.1365-2516.2008.01674.x. Epub 2008 Feb 25.
9
Economic and epidemiological modelling of full-length antihaemophilic factor (recombinant), plasma/albumin-free method, in previously treated patients with haemophilia A : comparison with B-domain deleted rFVIII, and value of potential viral transmission reduction due to plasma/albumin-free status.全长抗血友病因子（重组）、无血浆/白蛋白方法在既往治疗的甲型血友病患者中的经济和流行病学建模：与B结构域缺失的重组FVIII比较，以及无血浆/白蛋白状态在降低潜在病毒传播方面的价值
Drugs R D. 2005;6(3):149-56. doi: 10.2165/00126839-200506030-00003.
10
Virucidal treatment of clotting factor concentrates.
Lancet. 1988 Oct 1;2(8614):782-5. doi: 10.1016/s0140-6736(88)92426-9.
Zotero 插件